Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Pignolo RJ, Samsonraj RM, Law SF, Wang H, Chandra A.

Curr Osteoporos Rep. 2019 Apr;17(2):70-85. doi: 10.1007/s11914-019-00504-2. Review.

PMID:
30806947
2.

Working in the dead of night: exploring the transition to after-hours duty.

Walzak A, Butler D, Bates J, Farrell L, Law SFB, Pratt DD.

Med Educ. 2019 Mar;53(3):296-305. doi: 10.1111/medu.13762. Epub 2018 Nov 25.

PMID:
30474125
3.

Assertive Community Treatment in China - it is time for a made-in-China solution.

Law SF, Luo X, Yao S, Wang X.

Psychol Med. 2019 Jan;49(1):172-174. doi: 10.1017/S0033291718003094. Epub 2018 Oct 22. No abstract available.

PMID:
30345937
4.

Effectiveness of an Assertive Community Treatment program for people with severe schizophrenia in mainland China - a 12-month randomized controlled trial.

Luo X, Law SF, Wang X, Shi J, Zeng W, Ma X, Chow W, Liu S, Zhao W, Liu X, Yao S, Phillips MR.

Psychol Med. 2019 Apr;49(6):969-979. doi: 10.1017/S0033291718001629. Epub 2018 Jul 2.

PMID:
29962366
5.

Addressing Complexity and Improving Access in Community Mental Health Services: An Inner-City Adaptation of Flexible ACT.

Nakhost A, Law SF, Francombe Pridham KM, Stergiopoulos V.

Psychiatr Serv. 2017 Sep 1;68(9):867-869. doi: 10.1176/appi.ps.201700195. Epub 2017 Aug 15.

PMID:
28806892
6.

Adherence to Antipsychotic Medication by Community-Based Patients With Schizophrenia in China: A Cross-Sectional Study.

Wang X, Zhang W, Ma N, Guan L, Law SF, Yu X, Ma H.

Psychiatr Serv. 2016 Apr 1;67(4):431-7. doi: 10.1176/appi.ps.201500056. Epub 2016 Jan 4.

PMID:
26725294
7.

Perception of Coercion Among Patients With a Psychiatric Community Treatment Order: A Literature Review.

Pridham KM, Berntson A, Simpson AI, Law SF, Stergiopoulos V, Nakhost A.

Psychiatr Serv. 2016 Jan;67(1):16-28. doi: 10.1176/appi.ps.201400538. Epub 2015 Oct 1. Review.

PMID:
26423101
8.

Introducing psychiatry to rural physicians in China: an innovative education project.

Law SF, Liu P, Hodges BD, Shera W, Huang X, Zaheer J, Links PS.

Am J Psychiatry. 2011 Dec;168(12):1249-54. doi: 10.1176/appi.ajp.2011.11040654. No abstract available.

PMID:
22193670
9.
10.

Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.

van Seventer GA, Salmen HJ, Law SF, O'Neill GM, Mullen MM, Franz AM, Kanner SB, Golemis EA, van Seventer JM.

Eur J Immunol. 2001 May;31(5):1417-27.

11.

A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1.

Liu X, Elia AE, Law SF, Golemis EA, Farley J, Wang T.

EMBO J. 2000 Dec 15;19(24):6759-69.

12.

The docking protein HEF1 is an apoptotic mediator at focal adhesion sites.

Law SF, O'Neill GM, Fashena SJ, Einarson MB, Golemis EA.

Mol Cell Biol. 2000 Jul;20(14):5184-95.

13.

Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain.

Law SF, Zhang YZ, Fashena SJ, Toby G, Estojak J, Golemis EA.

Exp Cell Res. 1999 Oct 10;252(1):224-35.

PMID:
10502414
14.

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

Law SF, Schachar RJ.

J Am Acad Child Adolesc Psychiatry. 1999 Aug;38(8):944-51.

PMID:
10434485
15.
16.

Vectors to target protein domains to different cellular compartments.

Toby G, Law SF, Golemis EA.

Biotechniques. 1998 Apr;24(4):637-40.

17.

Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells.

Astier A, Manié SN, Law SF, Canty T, Haghayghi N, Druker BJ, Salgia R, Golemis EA, Freedman AS.

Leuk Lymphoma. 1997 Dec;28(1-2):65-72.

PMID:
9498705
18.

The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1.

Astier A, Manié SN, Avraham H, Hirai H, Law SF, Zhang Y, Golemis EA, Fu Y, Druker BJ, Haghayeghi N, Freedman AS, Avraham S.

J Biol Chem. 1997 Aug 8;272(32):19719-24.

19.
20.

Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).

Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD.

J Biol Chem. 1997 May 30;272(22):14320-6.

21.

Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells.

Manié SN, Beck AR, Astier A, Law SF, Canty T, Hirai H, Druker BJ, Avraham H, Haghayeghi N, Sattler M, Salgia R, Griffin JD, Golemis EA, Freedman AS.

J Biol Chem. 1997 Feb 14;272(7):4230-6.

22.

Molecular regulation of opioid receptors.

Blake AD, Bot G, Tallent M, Law SF, Li S, Freeman JC, Reisine T.

Receptors Channels. 1997;5(3-4):231-5. Review.

PMID:
9606728
24.

Molecular mechanisms of opiate receptor coupling to G proteins and effector systems.

Reisine T, Law SF, Blake A, Tallent M.

Ann N Y Acad Sci. 1996 Mar 22;780:168-75. Review. No abstract available.

PMID:
8602730
25.

Molecular biology of somatostatin receptors.

Bell GI, Yasuda K, Kong H, Law SF, Raynor K, Reisine T.

Ciba Found Symp. 1995;190:65-79; discussion 80-8. Review.

PMID:
7587653
26.

Somatostatin receptor activation of cellular effector systems.

Law SF, Woulfe D, Reisine T.

Cell Signal. 1995 Jan;7(1):1-8. Review.

PMID:
7538774
28.

Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2.

Law SF, Yasuda K, Bell GI, Reisine T.

J Biol Chem. 1993 May 25;268(15):10721-7.

29.

Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase.

Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI, Seino S.

Mol Endocrinol. 1992 Dec;6(12):2136-42.

PMID:
1337145
30.

Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.

Yasuda K, Rens-Domiano S, Breder CD, Law SF, Saper CB, Reisine T, Bell GI.

J Biol Chem. 1992 Oct 5;267(28):20422-8.

32.

Pharmacological properties of two cloned somatostatin receptors.

Rens-Domiano S, Law SF, Yamada Y, Seino S, Bell GI, Reisine T.

Mol Pharmacol. 1992 Jul;42(1):28-34.

PMID:
1353250
33.

Development of antibodies against the rat brain somatostatin receptor.

Theveniau M, Rens-Domiano S, Law SF, Rougon G, Reisine T.

Proc Natl Acad Sci U S A. 1992 May 15;89(10):4314-8.

34.

Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors.

Law SF, Manning D, Reisine T.

J Biol Chem. 1991 Sep 25;266(27):17885-97.

35.

Solubilization of active somatostatin receptors from rat brain.

He HT, Rens-Domiano S, Martin JM, Law SF, Borislow S, Woolkalis M, Manning D, Reisine T.

Mol Pharmacol. 1990 May;37(5):614-21.

PMID:
1971088

Supplemental Content

Support Center